APTO
Aptose Biosciences Inc
NASDAQ: APTO · HEALTHCARE · BIOTECHNOLOGY
$1.71
+0.00% today
Updated 2026-04-30
Market cap
$4.36M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-36.38
Dividend yield
—
52W range
$0 – $0
Volume
—
Aptose Biosciences Inc (APTO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-16.5%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-2323.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2024-12-31 | $-6.78 | $-34.90 | -415.1% | — | — |
| 2024-09-30 | $-1.19 | $-0.37 | +68.9% | — | — |
| 2024-06-30 | $-1.18 | $-0.43 | +63.6% | — | — |
| 2024-03-31 | $-0.74 | $-0.73 | +1.4% | $955269.00 | — |
| 2023-12-31 | $-1.59 | $-1.44 | +9.4% | $712206.00 | — |
| 2023-09-30 | $-2.05 | $-1.76 | +14.1% | — | — |
| 2023-06-30 | $-2.01 | $-2.27 | -12.9% | — | — |
| 2023-03-31 | $-0.12 | $-0.15 | -25.0% | — | — |
| 2022-12-31 | $-0.11 | $-0.11 | +0.0% | — | — |
| 2022-09-30 | $-0.12 | $-0.11 | +8.3% | — | — |
| 2022-06-30 | $-0.13 | $-0.11 | +15.4% | — | — |
| 2022-03-31 | $-0.15 | $-0.12 | +20.0% | — | — |
| 2021-12-31 | $-0.17 | $-0.27 | -58.8% | — | — |
Frequently asked questions
Has Aptose Biosciences Inc beaten earnings estimates?
Aptose Biosciences Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -16.5% over the last 4 quarters.